Permethrin lotion vs permethrin cream
permethrin 1% lotion vs 5% cream indications scabies head lice
| Feature | Permethrin 1% Lotion/Cream Rinse | Permethrin 5% Cream |
|---|---|---|
| Brand names | Nix, Kwellada-P | Elimite, Acticin |
| Indication | Head lice (Pediculus humanus capitis), pubic lice (Phthirus pubis) | Scabies (Sarcoptes scabiei) |
| Concentration | 1% | 5% |
| Application site | Scalp and hair | Entire body neck-down (including under nails, skin folds) |
| Contact time | 10 minutes, then rinse | 8-14 hours (overnight), then wash off |
| Age approval | ≥2 months | Generally ≥2 months; use cautiously in infants |
| Prescription? | OTC | OTC/Prescription (varies by country) |
| Retreatment | Repeat in 9-10 days if live lice seen | Single application usually sufficient; repeat 1 week later for crusted scabies |
| Cost | $ (inexpensive) | $ (inexpensive) |
Permethrin 5% lotion and permethrin 5% cream
permethrin 5% lotion vs 5% cream difference scabies head lice formulation
https://pmc.ncbi.nlm.nih.gov/articles/PMC1117314
| Feature | Permethrin 5% Cream | Permethrin 5% Lotion |
|---|---|---|
| Vehicle | Cream base (emulsion, thicker, stays on skin) | Lotion base (thinner, more fluid) |
| Primary indication | Scabies (Sarcoptes scabiei) | Scabies (used interchangeably in many guidelines) |
| Brand names (examples) | Elimite, Acticin, Lyclear Dermal Cream | Kwellada-P Lotion, various generics |
| Application | Entire body, neck down; 8-14 hours contact time | Entire body, neck down; 8-12 hours contact time |
| Approval status | FDA-approved for scabies | Used in many countries; some are OTC generics |
"Children and adults with infestation should apply lotion or cream containing this scabicide over their entire body below the head." - AAP Red Book 2021
| Product | Concentration | Form | Use |
|---|---|---|---|
| Nix / Lyclear Cream Rinse | 1% | Cream rinse / lotion | Head lice (10 min, rinse off) |
| Elimite / Acticin | 5% | Cream | Scabies (8-14 hr, wash off) |
| Kwellada-P / generic | 5% | Lotion | Scabies (8-12 hr, wash off) |
Is there any treatment for low platelet count and what fluid recommended in this situation
thrombocytopenia treatment platelet transfusion threshold fluid management 2024
| Category | Examples |
|---|---|
| Immune destruction | ITP (immune thrombocytopenia), lupus, drug-induced (heparin, NSAIDs) |
| Platelet consumption | TTP, HUS, DIC, massive trauma, major surgery |
| Impaired production | Bone marrow failure, chemotherapy, aplastic anemia, leukemia, B12/folate deficiency |
| Sequestration | Hypersplenism (malaria, liver disease, sickle cell) |
| Infection | Dengue, HIV, EBV, CMV, sepsis |
| Dilutional | Massive IV fluid resuscitation, massive blood transfusion |
| Clinical Situation | Transfuse Platelets When Count Is... |
|---|---|
| Stable, non-bleeding patient | < 10,000/mm³ (prophylactic) |
| Active serious bleeding | < 50,000/mm³ |
| Pre-procedure (central line, LP) | < 20,000 - 50,000/mm³ |
| Neurosurgery / eye surgery | < 80,000 - 100,000/mm³ |
| ICH with thrombocytopenia | < 50,000/mm³ - fresh platelets immediately |
| TTP | Avoid platelet transfusion |
| Cause | Key Treatment | Fluid/Product |
|---|---|---|
| ITP (mild) | Observation | N/A |
| ITP (moderate) | Steroids, IVIG | Platelet transfusion only if life-threatening |
| ITP (chronic) | Rituximab, TPO agonists, splenectomy | - |
| TTP | Plasma exchange + steroids | FFP (replacement fluid); avoid platelet transfusion |
| HUS | Supportive, eculizumab (atypical) | IV crystalloids (aggressive hydration) |
| Dengue | Supportive; oral fluids | LR or NS IV; colloid only in refractory shock |
| Chemotherapy | Platelet transfusion | Platelets when < 10,000 |
| Drug-induced | Stop the drug | Transfuse only if life-threatening |
| Nutritional | Replace B12/folate | - |
| DIC | Treat cause + replace blood products | FFP + platelets + cryoprecipitate |
Can you suggest me treatment plan
thickened endometrium 16mm premenopausal 40 years treatment management guidelines
PID pelvic inflammatory disease POD fluid treatment antibiotic regimen CDC guidelines
https://www.obgproject.com/2016/07/21/pelvic-inflammatory-di…
| Finding | Detail | Clinical Significance |
|---|---|---|
| Thickened endometrium | ~16.9 mm | Requires investigation - possibly hormonal, hyperplasia, or malignancy |
| Left ovarian cyst | 4.3 x 2.2 cm | Simple-appearing; requires monitoring/evaluation |
| POD fluid (PID) | Free fluid in cul-de-sac | Suggests active pelvic infection |
| All other organs | Normal | No abdominal pathology |
Important note: This is a clinical guidance based on USG findings alone. A gynecologist must evaluate this patient, as treatment depends heavily on symptoms (pelvic pain, fever, menstrual irregularity, vaginal discharge), menstrual cycle phase, and examination findings.
| Scenario | Approach |
|---|---|
| Simple unilocular, no internal echoes | Watchful waiting - repeat USG in 6-8 weeks (ideally Day 5-7 of next cycle) |
| Cyst resolves | No further action needed |
| Cyst persists or grows >5-7 cm | Gynecology referral for possible laparoscopic cystectomy |
| Complex features (septations, solid areas, vascularity) | Urgent gynecology referral + CA-125, HE4 |
| Priority | Action | Timeframe |
|---|---|---|
| Urgent | Start PID antibiotics (Ceftriaxone IM + Doxycycline + Metronidazole) | Today |
| Urgent | STI swabs (gonorrhea, chlamydia) | Today |
| Urgent | CBC, CRP, pregnancy test | Today |
| Within 72 hours | Reassess clinical response to antibiotics | Day 3 |
| Next cycle (Days 4-6) | Repeat TVS to reassess endometrial thickness | 2-4 weeks |
| If thickening persists | Endometrial biopsy | After next TVS |
| 6-8 weeks | Repeat USG to monitor left ovarian cyst | 6-8 weeks |
| Ongoing | Partner evaluation and treatment for PID | Concurrent |
⚠️ Disclaimer: This treatment plan is for educational guidance only and must be reviewed and implemented by a qualified gynecologist who can examine the patient, correlate symptoms, and individualize treatment.
She has complain of bleeding since 15 day
abnormal uterine bleeding 15 days thickened endometrium 16mm 40 year old treatment management
| Finding | Significance Now |
|---|---|
| Bleeding for 15 consecutive days | Abnormal uterine bleeding (AUB) - pathological, not a normal period |
| Endometrium 16.9 mm | In the context of prolonged bleeding, this is definitely abnormal - normal secretory max is 16-18 mm only in an intact ovulatory cycle, not with 15 days of bleeding |
| Left ovarian cyst 4.3 cm | May be a hormone-secreting follicular cyst causing estrogen-driven endometrial proliferation and anovulatory bleeding |
| POD fluid / PID | Concurrent pelvic infection contributing to bleeding |
| Age 40 | Perimenopausal age - higher risk of endometrial hyperplasia/malignancy |
⚠️ Malignancy must be excluded first. Prolonged bleeding + thickened endometrium at age 40 mandates endometrial biopsy before or alongside medical treatment.
| Test | Purpose |
|---|---|
| CBC + Hemoglobin | Assess degree of anemia from 15 days of bleeding |
| Pregnancy test (urine/serum βhCG) | Rule out ectopic pregnancy or gestational trophoblastic disease |
| Coagulation profile (PT, aPTT, bleeding time) | Rule out bleeding disorder |
| Thyroid function (TSH) | Hypothyroidism is a common cause of heavy/prolonged bleeding |
| Endometrial biopsy (Pipelle) | Mandatory at age 40 with AUB - rule out hyperplasia and endometrial carcinoma |
| Transvaginal ultrasound (TVS) | Better characterization of endometrium and ovarian cyst |
| Cervical/vaginal swabs | For gonorrhea, chlamydia (PID) |
| CRP/ESR | PID severity |
| Blood group and cross-match | If bleeding is heavy, may need transfusion |
| LFT, RFT, blood sugar | Baseline before starting medications |
| Timeframe | Action |
|---|---|
| 72 hours | Review CBC, reassess bleeding control, PID response |
| 1 week | Confirm biopsy result, review STI swabs |
| 2 weeks | Complete antibiotic course; review bleeding - should be stopped |
| 6-8 weeks | Repeat TVS to reassess endometrium and ovarian cyst |
| 3 months | Retest for gonorrhea/chlamydia if positive initially |
| 6 months | Repeat endometrial biopsy if hyperplasia was found |
1. ⚡ URGENT: CBC, pregnancy test, endometrial biopsy
2. ⚡ URGENT: Start PID antibiotics (Ceftriaxone IM + Doxycycline + Metronidazole)
3. 🩸 STOP BLEEDING: High-dose progestin + Tranexamic acid + NSAID
4. 💊 Iron supplementation for anemia
5. 📋 Await biopsy - tailor long-term therapy to result
6. 🔄 Repeat TVS at 6-8 weeks for cyst and endometrium
⚠️ This patient must be evaluated by a gynecologist in person. 15 days of bleeding with a thickened endometrium at age 40 requires urgent endometrial biopsy to exclude malignancy before full treatment is initiated.
She already taken trenexa 500 bd for 3 days
tranexamic acid not stopping bleeding 3 days next treatment step add progestin norethisterone
| Detail | |
|---|---|
| Trenexa (tranexamic acid) 500 mg BD | She is on a sub-therapeutic dose - the effective dose for heavy menstrual bleeding is 1g (1000 mg) 3 times daily (3g/day), not 500 mg twice daily (only 1g/day) |
| 3 days on tranexamic acid | Maximum benefit of tranexamic acid is seen within 2-5 days at full dose |
| Still bleeding at day 15 + 3 days | Tranexamic acid alone is insufficient - it is an antifibrinolytic that reduces blood loss volume but does not address the hormonal cause (anovulation, excess estrogen from ovarian cyst) |
Norethisterone is widely available in India and most appropriate here given the clinical scenario.
| Drug | Dose | Frequency | Duration | Purpose |
|---|---|---|---|---|
| Trenexa (tranexamic acid) | 1000 mg (increase from 500 mg) | 3x daily | Up to 5 days total | Reduce blood loss |
| Norethisterone 5 mg (NEW - add today) | 5 mg | 3x daily | Until bleeding stops (~5-7 days), then taper | Stabilize endometrium - treat root cause |
| Mefenamic acid 500 mg (NEW) | 500 mg | 3x daily with food | While bleeding active | Reduce prostaglandin-driven loss + pain |
| Ceftriaxone 500 mg (NEW) | 500 mg IM | Single dose | Day 1 only | PID - cover gonorrhea |
| Doxycycline 100 mg (NEW) | 100 mg | Twice daily | 14 days | PID - cover chlamydia |
| Metronidazole 400 mg (NEW) | 400 mg | Twice daily | 14 days | PID - anaerobic coverage + POD fluid |
| Ferrous sulfate/ascorbate (NEW) | 200 mg | Twice daily | 3 months | Correct iron deficiency anemia |
⚠️ If Hb is below 8 g/dL, consider referral for IV iron infusion or blood transfusion alongside the above treatment.
What is diagnosis and management
BPH grade 2 tamsulosin finasteride treatment post void residual 45ml cystitis management 60 year male
| # | Diagnosis | Key USG Finding |
|---|---|---|
| 1 | Left Renal Calculus | 5.7 mm stone at mid-lower pole of left kidney |
| 2 | Right Mild Hydronephrosis | Mild dilatation of right pelvicalyceal system - secondary to ureteric pathology (likely right-sided ureteric calculus not visualized) |
| 3 | Cystitis | Bladder wall oedematous, thickened to 7.5 mm, irregular margins |
| 4 | Benign Prostatic Enlargement (BPE) Grade II | Prostate 3.6 x 4.6 x 4.0 cm, weight 36g; PVR 45 mL |
| Test | Purpose |
|---|---|
| Renal Function Test (RFT/KFT) | USG specifically advises this - hydronephrosis may be compromising right kidney |
| Urine routine + microscopy + culture/sensitivity | Confirm cystitis organism, guide antibiotic choice |
| PSA (Prostate Specific Antigen) | Mandatory in 60-year-old with enlarged prostate - exclude prostate cancer |
| Serum creatinine + BUN + electrolytes | Assess degree of renal impairment |
| Urine stone analysis / 24-hour urine | Stone composition guides prevention |
| X-ray KUB (Kidney-Ureter-Bladder) | Detect radio-opaque stones; map right ureteric stone |
| CT KUB (non-contrast) | Gold standard for stone detection + size + location - especially for the right side obstruction causing hydronephrosis |
| Serum calcium, uric acid | Metabolic cause of stones |
| CBC | Infection severity |
Adjust antibiotic based on urine culture sensitivity report once available.
| Drug | Dose | Frequency | Duration | Indication |
|---|---|---|---|---|
| Tamsulosin 0.4 mg | 0.4 mg | Once daily (bedtime) | Long-term | BPH + Stone expulsion (dual use) |
| Ciprofloxacin 500 mg | 500 mg | Twice daily | 7-10 days | Cystitis (complicated UTI) |
| Diclofenac 50 mg | 50 mg | 3x daily with food | As needed for pain | Stone-related pain |
| ORS / High fluid intake | 2.5-3 L/day | Throughout day | Ongoing | Stone passage + hydration |
| Finasteride 5 mg | 5 mg | Once daily | Long-term | BPH (start after PSA checked) |
| Timeframe | Action |
|---|---|
| Today | Urine C&S, RFT, PSA, CT KUB, CBC |
| 48-72 hours | Review culture result, adjust antibiotic if needed |
| 1 week | Re-assess symptoms; review RFT |
| 2-4 weeks | Strain urine for stone passage; repeat USG for hydronephrosis |
| 4 weeks | If stone not passed → urology referral for ureteroscopy/ESWL |
| 6 weeks | Reassess PVR after tamsulosin; PSA review before finasteride |
| 3-6 months | Long-term prostate size monitoring |
How to stop symptomatic sign like frequent urine
how to reduce urinary frequency in BPH cystitis male tamsulosin bladder training lifestyle
BPH (Enlarged Prostate) Cystitis (Bladder Infection)
↓ ↓
Blocks urine outflow Inflamed bladder wall (7.5mm)
Bladder never fully empties Sends constant "full" signals
PVR 45 mL stays in bladder + Irritates stretch receptors
↓ ↓
= Urgency + Frequency + Nocturia
Expect meaningful improvement in frequency, urgency, and flow within 1-2 weeks.
| Step | Instructions |
|---|---|
| Keep a bladder diary | Record each time he urinates, how much urine, any urgency |
| Timed voiding | Set fixed toilet times - every 2 hours, gradually extend to every 2.5 then 3 hours |
| Urge suppression technique | When sudden urge hits, stop, stand still or sit, contract pelvic floor (like stopping urine midstream), breathe slowly - let the urge pass, then walk calmly to toilet |
| Do NOT rush to toilet | Rushing worsens urgency; slow, controlled walking reduces the urge signal |
| Goal | Extend interval between voids from ~1 hour to 3-4 hours over 4-6 weeks |
| Change | Why It Helps |
|---|---|
| Avoid caffeine (tea, coffee, cola) | Caffeine is a diuretic AND direct bladder irritant - major driver of frequency |
| Avoid alcohol | Direct bladder irritant, diuretic effect |
| Reduce evening fluids | Cut fluid intake 2-3 hours before bedtime - reduces nocturia significantly |
| Double voiding | After urinating, wait 30 seconds and try again - empties the residual 45 mL, reduces urgency afterward |
| Total daily fluid | Maintain 1.5-2 L/day (do not restrict too much - concentrated urine irritates the bladder more) |
| Spread fluid intake | Take fluids in morning and afternoon, reduce in evening |
| Avoid spicy food | Can irritate bladder |
| Healthy weight | Reduces abdominal pressure on bladder |
| Drug | Dose | How It Works |
|---|---|---|
| Mirabegron (beta-3 agonist) | 50 mg once daily | Relaxes bladder muscle, increases bladder capacity - safer in BPH than anticholinergics |
| Solifenacin (anticholinergic) | 5 mg once daily | Blocks bladder overactivity - use cautiously in BPH, may worsen retention |
| Oxybutynin | 5 mg twice daily | Older anticholinergic - effective but more side effects |
Mirabegron is preferred in elderly men with BPH because it does not increase urinary retention risk.
| Priority | Action | Expected Improvement |
|---|---|---|
| 1st | Ciprofloxacin (clear infection) | Urgency/frequency from cystitis gone in 1-3 days |
| 2nd | Tamsulosin 0.4 mg at bedtime | Better flow + reduced frequency in 1-2 weeks |
| 3rd | Cut caffeine, alcohol, evening fluids | Nocturia improves immediately |
| 4th | Double voiding after each void | Reduces PVR, less urgency between voids |
| 5th | Bladder training | Progressive improvement over 4-6 weeks |
| 6th | Add Mirabegron 50 mg if needed | For residual overactive bladder symptoms |
Management of white discharge in female
| Feature | Description |
|---|---|
| Color | Clear to white |
| Odor | Odorless or mild |
| Consistency | Thin, watery or slightly mucoid |
| Itching/burning | None |
| When it occurs | Mid-cycle (ovulation), premenstrual, pregnancy, sexual arousal, newborns, puberty |
| pH | ≤ 4.5 (acidic - normal lactobacilli-dominant environment) |
| Feature | Bacterial Vaginosis (BV) | Vulvovaginal Candidiasis | Trichomoniasis |
|---|---|---|---|
| Causative agent | Gardnerella vaginalis + anaerobes | Candida albicans | Trichomonas vaginalis |
| % of vaginitis | 40% (most common) | 30% | 20% |
| Discharge color | White or gray | White (thick, curd-like) | White or yellow-green |
| Consistency | Thin, homogeneous, coats vaginal walls | Clumped, adherent plaques | Profuse, homogeneous |
| Odor | Fishy ("amine") odor - worse after sex | No odor | Malodorous |
| Itching | Mild or absent | Intense vulvar itching | Present |
| Vaginal pH | > 4.5 | ≤ 4.5 (normal) | > 4.5 |
| Wet mount | Clue cells (epithelial cells studded with bacteria) | Pseudohyphae / budding yeast | Motile trichomonads |
| KOH (Whiff) test | Positive (fishy smell) | Pseudohyphae on KOH prep | Negative |
| Inflammation | None | Vulvar erythema, fissures | Vulvovaginal erythema |
| Cause | Feature | Treatment |
|---|---|---|
| Cervicitis (Chlamydia/Gonorrhea) | Mucopurulent discharge from cervical os, post-coital bleeding | Ceftriaxone 500 mg IM + Doxycycline 100 mg BD x 7 days |
| Atrophic vaginitis (postmenopausal) | Thin watery discharge, dryness, dyspareunia, no infection | Topical estrogen cream (Estriol) or vaginal moisturizers |
| Desquamative inflammatory vaginitis | Profuse purulent discharge, parabasal cells on smear | Clindamycin 2% vaginal cream + topical steroid for weeks |
| Foreign body (forgotten tampon, IUCD) | Offensive discharge, unilateral; often missed | Remove foreign body; antibiotics if secondary infection |
| Physiological excess (pregnancy, OCP) | Clear/white, no odor or itch | Reassurance, hygiene |
| Test | Purpose |
|---|---|
| Vaginal pH (litmus paper) | >4.5 = BV or Trichomonas; ≤4.5 = Candida or normal |
| Wet mount microscopy | Clue cells (BV), motile trichomonads, hyphae (Candida) |
| KOH preparation | Pseudohyphae = Candida; Whiff test = BV |
| High vaginal swab (HVS) C&S | Culture to identify organism and guide treatment |
| Endocervical swab | For gonorrhea and chlamydia NAAT |
| Pap smear | If not done recently; rule out cervical pathology |
| Blood glucose / HbA1c | If recurrent candidiasis - rule out diabetes |
| HIV test | If recurrent or refractory infection |
| Pregnancy test | Before starting oral antifungals/metronidazole |
| Advice | Reason |
|---|---|
| Avoid vaginal douching | Destroys normal lactobacilli flora, worsens BV and candida |
| Wear cotton, loose underwear | Reduces moisture and fungal growth |
| Avoid tight synthetic clothing | Increases local heat and humidity |
| Wipe front to back after toilet | Prevents bowel flora entering vagina |
| Avoid scented soaps, sprays, panty liners | Chemical irritants disrupt vaginal pH |
| Safe sex / condom use | Reduces risk of trichomoniasis and STI-related discharge |
| Control blood sugar (if diabetic) | Hyperglycemia directly promotes Candida overgrowth |
| Probiotics (Lactobacillus rhamnosus) | May reduce recurrence of BV and candida |
WHITE DISCHARGE
│
├── Thick, curd-like + ITCHING + no odor → CANDIDA
│ → Fluconazole 150mg single dose oral
│
├── Thin, homogeneous + FISHY ODOR + no itch → BV
│ → Metronidazole 500mg BD x 7 days
│
├── Frothy, profuse + OFFENSIVE + sexual contact → TRICHOMONAS
│ → Metronidazole 2g single dose + treat partner
│
├── From cervix + post-coital bleed → CERVICITIS
│ → Ceftriaxone + Doxycycline
│
└── Postmenopausal + dry + no infection → ATROPHIC
→ Topical estrogen cream
A 60 year lady has pain in LLQ since 15 day but last has diarrhea also what is DD and management
| Priority | Diagnosis | Key Clues |
|---|---|---|
| ⭐ Most likely | Acute/Subacute Diverticulitis | Age >50, LLQ, fever, altered bowel habit, constipation alternating with diarrhea |
| 🔴 Must exclude | Colorectal Carcinoma (sigmoid/descending) | Age 60F, chronic pain, change in bowel habit - classic red flag |
| ⚠️ Important | Inflammatory Bowel Disease (Crohn's/UC flare) | Chronic diarrhea, LLQ pain, blood/mucus in stool |
| ⚠️ | Ischemic Colitis | Age + vascular risk factors; LLQ + bloody diarrhea |
| ⚠️ | Infectious Colitis | Acute onset diarrhea, fever, recent travel/antibiotics |
| 🔷 Consider | Irritable Bowel Syndrome | Younger onset, functional, but pain relieved by defecation |
| 🔷 | Ovarian Pathology (cyst, torsion) | Female, LLQ; though unlikely at 60 without hormonal context |
| 🔷 | Left ureteric colic | Colicky pain radiating to groin; hematuria |
| 🔷 | Mesenteric Lymphadenitis | Usually younger patients |
| 🔷 | Hernia (left inguinal/femoral) | Palpable swelling, worse on standing |
| 🔷 | Psoas abscess | Fever, hip flexion posture, iliopsoas sign |
15 days of pain suggests subacute or smoldering diverticulitis - this pattern is important because it may indicate a pericolic abscess or early fistula formation rather than simple uncomplicated disease.
| Test | Purpose |
|---|---|
| CBC | WBC elevated in diverticulitis/infection; anemia suggests malignancy or IBD |
| CRP / ESR | Elevated in diverticulitis, IBD, malignancy |
| Serum electrolytes, creatinine | Baseline; diarrhea causes electrolyte loss |
| Urine routine + microscopy | Rule out left ureteric colic, UTI |
| Stool routine + culture + C. difficile | Rule out infectious colitis |
| Stool occult blood (FOBT) | Malignancy screening; IBD |
| Serum lactate | If ischemic colitis suspected (peritoneal signs + pain out of proportion) |
| Pregnancy test | Always in women of reproductive age (not needed here at 60 unless perimenopausal) |
| Test | Purpose |
|---|---|
| CT abdomen + pelvis with IV contrast | First choice - sensitivity 97%, specificity ~100% for diverticulitis; detects complications (abscess, perforation, fistula); also screens for malignancy |
| Ultrasound abdomen | Operator-dependent; sensitivity >80% for diverticulitis in experienced hands; less preferred over CT but useful if CT unavailable or radiation concern |
| X-ray abdomen (erect + supine) | Quick screen for free air (perforation), obstruction |
| Test | Purpose |
|---|---|
| Colonoscopy (6-8 weeks after recovery) | Mandatory - exclude malignancy, confirm diverticular disease, assess IBD |
| CEA (carcinoembryonic antigen) | Tumor marker for colorectal cancer (not diagnostic alone) |
| MRI pelvis | If fistula, pelvic abscess, or ovarian pathology suspected |
| Stage | Finding | Treatment |
|---|---|---|
| I | Pericolic abscess | Antibiotics ± CT-guided drainage |
| II | Pelvic/distant abscess | Antibiotics + CT-guided drainage |
| III | Purulent peritonitis | Emergency surgery |
| IV | Fecal peritonitis | Emergency surgery |
| Complication | Management |
|---|---|
| Abscess (Hinchey I/II) | IV antibiotics + CT-guided percutaneous drainage if >4 cm |
| Obstruction | IV antibiotics, bowel rest, surgical consult |
| Fistula (colovesical, colovaginal) | Elective surgical resection after inflammation resolves |
| Perforation with peritonitis (Hinchey III/IV) | Emergency laparotomy - Hartmann's procedure or primary anastomosis |
| Action | Timeframe |
|---|---|
| Colonoscopy | 6-8 weeks after acute episode resolves (mandatory to exclude malignancy) |
| High-fiber diet | Long-term - reduces recurrence of diverticulitis |
| Adequate hydration | 2+ litres/day |
| Avoid NSAIDs and steroids | Both increase diverticulitis risk and severity |
| Elective sigmoid colectomy | Discussed in recurrent episodes (≥2 attacks) or complicated disease; individualized decision |
| Colorectal cancer surveillance | Colonoscopy per age-appropriate guidelines |
60F, LLQ pain 15 days + diarrhea
↓
CT abdomen + pelvis (IV contrast)
↓
┌──────────────────────────────┐
│ │
Uncomplicated Complicated
diverticulitis (abscess/perforation)
│ │
Mild → Outpatient Abscess → Drain + IV ABx
Antibiotics 4-7 days Peritonitis → Surgery
Diet modification
│
↓
Colonoscopy at 6-8 weeks
(rule out colorectal cancer)
USG shows normal